BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18703116)

  • 1. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.
    Utsunomiya K; Shinkai T; De Luca V; Hwang R; Sakata S; Fukunaka Y; Chen HI; Ohmori O; Nakamura J
    Neurosci Lett; 2008 Oct; 444(2):161-5. PubMed ID: 18703116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.
    Utsunomiya K; Shinkai T; Sakata S; Yamada K; Chen HI; De Luca V; Hwang R; Ohmori O; Nakamura J
    Neurosci Lett; 2012 Jan; 507(1):52-6. PubMed ID: 22172931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis.
    Liu C; Xu X; Liu X; Zhang T; Li Y; Yan P
    Neurosci Lett; 2022 Aug; 786():136788. PubMed ID: 35835396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis.
    Ma G; He Z; Fang W; Tang W; Huang K; Li Z; He G; Xu Y; Feng G; Zheng T; Zhou J; He L; Shi Y
    Schizophr Res; 2008 Apr; 101(1-3):26-35. PubMed ID: 18295456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.
    Jönsson EG; Flyckt L; Burgert E; Crocq MA; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Nimgaonkar VL; Edman G; Bjerkenstedt L; Wiesel FA; Sedvall GC
    Psychiatr Genet; 2003 Mar; 13(1):1-12. PubMed ID: 12605094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between the DRD3 Ser9Gly polymorphism and schizophrenia.
    Fathalli F; Rouleau GA; Xiong L; Tabbane K; Benkelfat C; Deguzman R; Zoltan D; Lal S; D'cruz S; Joober R
    Schizophr Res; 2008 Jan; 98(1-3):98-104. PubMed ID: 17698325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor.
    Mao X; Wang T; Liu M; Chang X; Li N; Gu Y; Zhao D; Liao Q; Peng R
    J Clin Neurosci; 2013 Dec; 20(12):1644-9. PubMed ID: 24054403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the DRD2 CA
    Xu S; Liu J; Yang X; Qian Y; Xiao Q
    J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
    Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
    Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Association Analysis of Dopamine DRD3 Ser9Gly Polymorphism and Schizophrenia in Malay Population.
    Tee S; Tang P; Loh H
    Iran J Public Health; 2011; 40(2):6-10. PubMed ID: 23113067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia.
    Chen CH; Liu MY; Wei FC; Koong FJ; Hwu HG; Hsiao KJ
    Am J Med Genet; 1997 Feb; 74(1):40-3. PubMed ID: 9034004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
    Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
    Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
    Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
    Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.
    Ishiguro H; Okuyama Y; Toru M; Arinami T
    Mol Psychiatry; 2000 Jul; 5(4):433-8. PubMed ID: 10889555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample.
    Lorenzo CV; Baca-Garcia E; Hernandez MD; Martin CB; Perez-Rodriguez MM; Saiz-Gonzalez MD; Fernández P; Gutierrez FJ; Saiz-Ruiz J; Piqueras JF; de Rivera JL; de Leon J
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):344-6. PubMed ID: 17171662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between dopamine D3 receptor Ser9Gly polymorphism and schizophrenia in Han Chinese population.
    Chang HA; Lu RB; Lin WW; Chang CC; Chen CL; Shy MJ; Huang SY
    Acta Neuropsychiatr; 2007 Dec; 19(6):344-50. PubMed ID: 26952999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.
    Barlas IO; Cetin M; Erdal ME; Semiz UB; Basoglu C; Ay ME; Herken H; Uzun O
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):56-60. PubMed ID: 18449897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
    Malhotra AK; Goldman D; Buchanan RW; Rooney W; Clifton A; Kosmidis MH; Breier A; Pickar D
    Mol Psychiatry; 1998 Jan; 3(1):72-5. PubMed ID: 9491816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.